Home › Myasthenia Gravis › Texas
Myasthenia Gravis clinical trials in Texas
16 studies for Myasthenia Gravis are looking for participants at sites in Texas.
Cities in Texas
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1003, Dallas
- Site Number - 1047, Denton
- Site Number - 1057, Houston
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07673627Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Austin Neuromuscular Center, Austin
- Texas Neurology, Dallas
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Nov 3, 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Houston
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 30, 2026 · NCT07647510ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07294170A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Austin Neuromuscular Center, Austin
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Oct 23, 2026 · NCT06987539Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- UT Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06626919Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
- ANESC Research, El Paso
- Baylor Scott & White Neurology - McKinney, McKinney
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06463587RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06359041ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07284420Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Houston
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Aug 3, 2026 · NCT07596901KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Houston Methodist Hospital, Houston
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- National Neuromuscular Research Institute, Austin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Nerve & Muscle Center of Texas, Houston
- Houston Methodist Neurological Institute, Houston
RecruitingPhase 1/2
Ages 18 to 74 · All sexes · Updated Feb 11, 2026 · NCT07250750Vitaccess Real MG Registry
- University of Texas Health Science Center at Houston, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06064461From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.